NASDAQ:ABEO - Abeona Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
Get Started
$7.44 -0.01 (-0.13 %)
(As of 05/19/2019 04:00 PM ET)
Previous Close$7.44
Today's Range$7.30 - $7.59
52-Week Range$6.26 - $21.45
Volume622,657 shs
Average Volume355,740 shs
Market Capitalization$365.75 million
P/E RatioN/A
Dividend YieldN/A
Beta1.92

Headlines

Abeona Therapeutics (NASDAQ ABEO) News Headlines

Source:
DateHeadline
Jefferies Financial Group Equities Analysts Cut Earnings Estimates for Abeona Therapeutics Inc (ABEO)Jefferies Financial Group Equities Analysts Cut Earnings Estimates for Abeona Therapeutics Inc (ABEO)
www.americanbankingnews.com - May 19 at 3:08 AM
Research Analysts Offer Predictions for Abeona Therapeutics Incs FY2023 Earnings (ABEO)Research Analysts Offer Predictions for Abeona Therapeutics Inc's FY2023 Earnings (ABEO)
www.americanbankingnews.com - May 17 at 7:39 AM
Research Analysts Offer Predictions for Abeona Therapeutics Incs Q2 2019 Earnings (ABEO)Research Analysts Offer Predictions for Abeona Therapeutics Inc's Q2 2019 Earnings (ABEO)
www.americanbankingnews.com - May 17 at 6:43 AM
Edited Transcript of ABEO earnings conference call or presentation 14-May-19 2:00pm GMTEdited Transcript of ABEO earnings conference call or presentation 14-May-19 2:00pm GMT
finance.yahoo.com - May 15 at 11:29 AM
Abeona Therapeutics Inc (ABEO) Q1 2019 Earnings Call TranscriptAbeona Therapeutics Inc (ABEO) Q1 2019 Earnings Call Transcript
www.fool.com - May 14 at 10:01 PM
Abeona Therapeutics (ABEO) Earns Buy Rating from Cantor FitzgeraldAbeona Therapeutics (ABEO) Earns Buy Rating from Cantor Fitzgerald
www.americanbankingnews.com - May 14 at 2:36 PM
Abeona Therapeutics Treats First Patient in Second Cohort of Phase 1/2 Clinical Trial for ABO-101 in Sanfilippo Syndrome Type B (MPS IIIB)Abeona Therapeutics Treats First Patient in Second Cohort of Phase 1/2 Clinical Trial for ABO-101 in Sanfilippo Syndrome Type B (MPS IIIB)
finance.yahoo.com - May 14 at 11:43 AM
Abeona Therapeutics Inc.: Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business HighlightsAbeona Therapeutics Inc.: Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights
www.finanznachrichten.de - May 11 at 11:27 AM
Abeona Therapeutics misses by $0.09Abeona Therapeutics misses by $0.09
seekingalpha.com - May 11 at 11:27 AM
Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business HighlightsAbeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights
www.globenewswire.com - May 11 at 11:27 AM
Abeona Therapeutics Inc.: Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual MeetingAbeona Therapeutics Inc.: Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meeting
www.finanznachrichten.de - May 8 at 11:25 AM
Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual MeetingAbeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meeting
finance.yahoo.com - May 8 at 11:25 AM
Abeona Therapeutics Announces Participation in Upcoming Investor ConferencesAbeona Therapeutics Announces Participation in Upcoming Investor Conferences
finance.yahoo.com - May 7 at 4:29 PM
Abeona Therapeutics Inc (ABEO) Receives Average Recommendation of "Buy" from BrokeragesAbeona Therapeutics Inc (ABEO) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 6 at 12:37 PM
Abeona Therapeutics (ABEO) Buy Rating Reaffirmed at HC WainwrightAbeona Therapeutics' (ABEO) Buy Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - May 6 at 10:32 AM
Abeona Therapeutics Inc (ABEO) Expected to Announce Quarterly Sales of $1.21 MillionAbeona Therapeutics Inc (ABEO) Expected to Announce Quarterly Sales of $1.21 Million
www.americanbankingnews.com - May 5 at 8:50 PM
-$0.31 Earnings Per Share Expected for Abeona Therapeutics Inc (ABEO) This Quarter-$0.31 Earnings Per Share Expected for Abeona Therapeutics Inc (ABEO) This Quarter
www.americanbankingnews.com - May 3 at 10:23 PM
Earnings Preview: Abeona Therapeutics (ABEO) Q1 Earnings Expected to DeclineEarnings Preview: Abeona Therapeutics (ABEO) Q1 Earnings Expected to Decline
finance.yahoo.com - May 3 at 4:23 PM
Abeona Therapeutics (ABEO) Given Buy Rating at Maxim GroupAbeona Therapeutics (ABEO) Given Buy Rating at Maxim Group
www.americanbankingnews.com - May 1 at 4:14 PM
Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual MeetingAbeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting
finance.yahoo.com - May 1 at 11:05 AM
Abeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual MeetingAbeona Therapeutics to Report New Preclinical Data Demonstrating Therapeutic Potential of ABO-401 for Treatment of Cystic Fibrosis at American Society of Gene and Cell Therapy Annual Meeting
finance.yahoo.com - April 30 at 11:05 AM
Is Abeona Therapeutics's (NASDAQ:ABEO) 173% Share Price Increase Well Justified?Is Abeona Therapeutics's (NASDAQ:ABEO) 173% Share Price Increase Well Justified?
finance.yahoo.com - April 16 at 1:05 PM
New IND-enabling data for ABO-202 in CLN1 disease also to be highlightedNew IND-enabling data for ABO-202 in CLN1 disease also to be highlighted
www.globenewswire.com - April 15 at 4:26 PM
Abeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual MeetingAbeona Therapeutics to Present Data for ABO-401 in Cystic Fibrosis and Retinal Disorders at the American Society of Gene and Cell Therapy Annual Meeting
finance.yahoo.com - April 15 at 4:26 PM
Abeona Therapeutics Inc.: Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)Abeona Therapeutics Inc.: Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
www.finanznachrichten.de - April 4 at 10:12 AM
Abeonas ABO-101 Fast Trackd for MPS IIIB; shares up 5% premarketAbeona's ABO-101 Fast Track'd for MPS IIIB; shares up 5% premarket
seekingalpha.com - April 4 at 10:12 AM
Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)Abeona Therapeutics Receives FDA Fast Track Designation for ABO-101 for Treatment of Sanfilippo Syndrome Type B (MPS IIIB)
finance.yahoo.com - April 4 at 10:12 AM
Edited Transcript of ABEO earnings conference call or presentation 19-Mar-19 2:00pm GMTEdited Transcript of ABEO earnings conference call or presentation 19-Mar-19 2:00pm GMT
finance.yahoo.com - March 20 at 11:22 AM
Abeona Therapeutics Inc. (ABEO) CEO João Siffert on Q4 2018 Results - Earnings Call TranscriptAbeona Therapeutics Inc. (ABEO) CEO João Siffert on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 19 at 4:18 PM
Abeona Therapeutics Inc.: Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial ResultsAbeona Therapeutics Inc.: Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
www.finanznachrichten.de - March 19 at 12:13 PM
Abeona Therapeutics Inc. (ABEO) After Hours TradingAbeona Therapeutics Inc. (ABEO) After Hours Trading
www.nasdaq.com - March 19 at 12:13 PM
Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial ResultsAbeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 19 at 12:13 PM
Abeona Therapeutics: 4Q Earnings SnapshotAbeona Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 19 at 12:13 PM
Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference - GlobeNewswireAbeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference - GlobeNewswire
globenewswire.com - February 22 at 4:00 PM
Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare ConferenceAbeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 22 at 12:56 PM
What Investors Should Know About Abeona Therapeutics Inc.’s (NASDAQ:ABEO) Financial StrengthWhat Investors Should Know About Abeona Therapeutics Inc.’s (NASDAQ:ABEO) Financial Strength
finance.yahoo.com - February 22 at 12:56 PM
Abeona Therapeutics (ABEO) Joao Siffert MD as New Chief Executive Officer - StreetInsider.comAbeona Therapeutics (ABEO) Joao Siffert MD as New Chief Executive Officer - StreetInsider.com
www.streetinsider.com - February 11 at 4:13 PM
Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer - GlobeNewswireAbeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer - GlobeNewswire
globenewswire.com - February 11 at 4:13 PM
Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive OfficerAbeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer
finance.yahoo.com - February 11 at 4:13 PM
Sangamo selloff weighs on gene therapy developers - Seeking AlphaSangamo selloff weighs on gene therapy developers - Seeking Alpha
seekingalpha.com - February 8 at 11:23 AM
Abeona up 13% ahead of gene therapy presentationsAbeona up 13% ahead of gene therapy presentations
seekingalpha.com - February 4 at 4:09 PM
Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™
finance.yahoo.com - January 31 at 11:00 AM
New finance chief at AbeonaNew finance chief at Abeona
seekingalpha.com - January 8 at 4:26 PM
Abeona Therapeutics Strengthens Financial Leadership with New Executive AppointmentsAbeona Therapeutics Strengthens Financial Leadership with New Executive Appointments
finance.yahoo.com - January 8 at 4:26 PM
How Should Investors Feel About Abeona Therapeutics Inc.’s (NASDAQ:ABEO) CEO Pay?How Should Investors Feel About Abeona Therapeutics Inc.’s (NASDAQ:ABEO) CEO Pay?
finance.yahoo.com - December 25 at 10:10 AM
Is Abeona Therapeutics Inc (ABEO) A Good Stock To Buy?Is Abeona Therapeutics Inc (ABEO) A Good Stock To Buy?
finance.yahoo.com - December 13 at 8:14 AM
Abeona Therapeutics (ABEO) in Focus: Stock Moves 5.5% HigherAbeona Therapeutics (ABEO) in Focus: Stock Moves 5.5% Higher
finance.yahoo.com - December 11 at 10:56 AM
Abeona to launch pivotal study of EB-101 in RDEB in mid-2019, new CF program launched; shares up 6%Abeona to launch pivotal study of EB-101 in RDEB in mid-2019, new CF program launched; shares up 6%
seekingalpha.com - December 6 at 4:10 PM
Abeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D DayAbeona Therapeutics Details Pathway for Advancing Lead Clinical Programs and Unveils New Cystic Fibrosis Program Born from Next Generation AIM™ Vector Platform at 2018 R&D Day
finance.yahoo.com - December 6 at 4:10 PM
Moving Average Crossover Alert: Abeona TherapeuticsMoving Average Crossover Alert: Abeona Therapeutics
finance.yahoo.com - December 3 at 10:26 AM
This page was last updated on 5/19/2019 by MarketBeat.com Staff

Featured Article: What are the benefits of a balanced fund?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel